Last edition
News about "Assertio Holdings"
Assertio Announces Completion of Merger with Zydus Lifesciences
Assertio has completed its merger with Zydus Lifesciences, becoming a wholly owned subsidiary of the company. Following the acquisition, Assertio shares have been delisted from Nasdaq, with shareholders receiving USD 23.50 per share in cash.
Assertio Holdings | 19/06/2026 | By News Bureau
Zydus Worldwide DMCC to Acquire Assertio Holdings
Zydus Worldwide DMCC to acquire Assertio Holdings in a USD 166.4 million all-cash deal at USD 23.50 per share.
Assertio Holdings | 14/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy